Yayın:
Anticancer Potential of Albumin Bound Wnt/β‐Catenin Pathway Inhibitor Niclosamide in Breast Cancer Cells

dc.contributor.authorBÜYÜKKÖROĞLU, GÜLAY
dc.contributor.authorMerve Erkısa
dc.contributor.authorGonca Pekel
dc.contributor.authorElif Ertürk
dc.contributor.authorGülay Büyükköroğlu
dc.contributor.authorEngı̇n Ulukaya
dc.contributor.orcid0000-0002-6729-7908
dc.contributor.orcid0000-0002-3127-742X
dc.contributor.orcid0000-0001-7668-796X
dc.contributor.orcid0000-0002-5089-6007
dc.contributor.orcid0000-0003-4875-5472
dc.date.accessioned2025-11-13T10:57:09Z
dc.date.issued2021-08-06
dc.identifier.doihttps://doi.org/10.1002/slct.202100819
dc.identifier.endpage7475
dc.identifier.issn2365-6549
dc.identifier.issue29
dc.identifier.openalexW3187406961
dc.identifier.startpage7463
dc.identifier.urihttps://hdl.handle.net/11421/5761
dc.identifier.urihttps://doi.org/10.1002/slct.202100819
dc.identifier.volume6
dc.language.isoen
dc.relation.ispartofChemistrySelect
dc.rightsrestrictedAccess
dc.subjectNiclosamide
dc.subjectApoptosis
dc.subjectFlow cytometry
dc.subjectAlbumin
dc.subjectWnt signaling pathway
dc.subjectBovine serum albumin
dc.subjectCancer research
dc.subjectBreast cancer
dc.subjectCancer cell
dc.subjectChemistry
dc.subjectCancer
dc.subjectPharmacology
dc.subjectMedicine
dc.subjectBiochemistry
dc.subjectBiology
dc.subjectSignal transduction
dc.subjectImmunology
dc.subjectInternal medicine
dc.subject.sdg3
dc.titleAnticancer Potential of Albumin Bound Wnt/β‐Catenin Pathway Inhibitor Niclosamide in Breast Cancer Cells
dc.typeArticle
dspace.entity.typePublication
local.authorid.openalexA5039206093

Dosyalar

Koleksiyonlar